PPH

VanEck Vectors Pharmaceutical ETF [PPH] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

PPH Stock Summary

Top 10 Correlated ETFs

PPH

Top 10 Correlated Stocks

PPH

In the News

PPH Financial details

Company Rating
-
Market Cap
987.04M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.43
Dividend %
2%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-2.15%
SMA50
5.81%
SMA100
-1.09%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
74.05-91.16
52W High
+0.37%
52W Low
+23.43%
RSI
45
Rel Volume
0.84
Avg Volume
125.56K
Volume
105.88K
Perf Week
-1.41%
Perf Month
2.55%
Perf Quarter
-2.04%
Perf Half Y
-3.7%
-
-
-
-
Beta
0.6
-
-
Volatility
0.73%, 1.45%
Prev Close
0.76%
Price
91.335
Change
0.8%

PPH Financial Performance

PPH Dividend History

PPH Frequently Asked Questions

What is VanEck Vectors Pharmaceutical ETF stock symbol ?

VanEck Vectors Pharmaceutical ETF is a US stock and trading under the symbol PPH

What is VanEck Vectors Pharmaceutical ETF stock quote today ?

VanEck Vectors Pharmaceutical ETF stock price is $91.335 today.

Is VanEck Vectors Pharmaceutical ETF stock public?

Yes, VanEck Vectors Pharmaceutical ETF is a publicly traded company.

Something similar

Top by Market Cap
FB2A.DE
TSLA
3V64.DE
EMBASSY.NS
FXAIX
Top Correlated ETFs
FHI.TO
VDCP.L
IXJ
DXSK.DE
XS3R.L
Top Correlated Stocks
MDT
002031.SZ
OVBC
0Y6X.L
JNJ
Similar Market Cap
PGRE
0F6L.L
DMLP
FFC
003560.KS

Company Profile

Financial Services Asset Management
  • Volume Average 125.56K
  • Market Capitalization 987.04M
  • Headquarters US
  • IPO Date 2000-02-01

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.